Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (691-700 of 706) with videos related to

Pageof 71
Sort By:
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|June 22, 2016
[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society]Marina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
European Heart Journal|May 27, 2015
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Samuel S Gidding, Gerald F Watts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Journal of the American College of Cardiology|June 30, 2018
The Role of Nutraceuticals in Statin Intolerant PatientsMaciej Banach, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Atherosclerosis|September 27, 2015
Familial hypercholesterolaemia: A global call to armsAntonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Pageof 71

Showing results (691-700 of 706) with videos related to

Sort By:
Pageof 71
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|June 22, 2016
[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society]Marina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
European Heart Journal|May 27, 2015
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Samuel S Gidding, Gerald F Watts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Journal of the American College of Cardiology|June 30, 2018
The Role of Nutraceuticals in Statin Intolerant PatientsMaciej Banach, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Atherosclerosis|September 27, 2015
Familial hypercholesterolaemia: A global call to armsAntonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Pageof 71